docetaxel anhydrous has been researched along with enzastaurin in 2 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 188 | 52 | 99 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Dreicer, R; Garcia, J; Kania, M; Raghavan, D; Rini, B; Shi, P; Somer, B; Srinivas, S; Vogelzang, N | 1 |
1 trial(s) available for docetaxel anhydrous and enzastaurin
Article | Year |
---|---|
A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Double-Blind Method; Humans; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Placebos; Prostatic Neoplasms, Castration-Resistant; Taxoids; Treatment Outcome | 2013 |
1 other study(ies) available for docetaxel anhydrous and enzastaurin
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |